scispace - formally typeset
K

Kurt Niederkorn

Researcher at Medical University of Graz

Publications -  91
Citations -  5731

Kurt Niederkorn is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Stroke & Hyperintensity. The author has an hindex of 27, co-authored 89 publications receiving 5048 citations. Previous affiliations of Kurt Niederkorn include Innsbruck Medical University & Health and Safety Executive.

Papers
More filters
Journal ArticleDOI

Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study.

TL;DR: The outcome of surgical patients with putaminal or thalamic hemorrhage was no better than for those with medical treatment; however, there was a trend toward better quality of survival and chance of survival in the operated group.
Journal ArticleDOI

White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.

TL;DR: The results indicate that a higher incidence of changes known to be associated with an increased risk for stroke exists in the presence of white matter lesions in normal elderly individuals.
Journal ArticleDOI

Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis

TL;DR: Applying these criteria to the MRIs of elderly patients with suspected MS should significantly improve specificity over current quantitative criteria (at least three AIS≥3 mm) without significantly decreasing sensitivity.
Journal ArticleDOI

Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

Bruce C.V. Campbell, +267 more
- 13 Jul 2019 - 
TL;DR: Patients with ischaemic stroke 4·5-9 h from stroke onset or wake-up stroke with salvageable brain tissue who were treated with alteplase achieved better functional outcomes than did patients given placebo, and this increase in the rate of symptomatic intracerebral haemorrhage did not negate the overall net benefit of thrombolysis.